In 2022,  Credit Pharmaceutical CO., LTD., through its wholly-owned subsidiary Fidelity BioPharma Co. (USA), officially launched the dietary supplement brand CreNeuroS."Cre" is derived from the first three letters of "Credit," symbolizing trust and credibility; "Neuro" translates to nerve or neurology, reflecting the brand's focus on the field of neuroscience; and "S" stands for Science, conveying the core philosophy of being based on scientific evidence. Furthermore, the three capital letters CNS in CreNeuroS are the internationally recognized abbreviation for the central nervous system, further highlighting the brand's focus on nervous system health.Brand Positioning: Focusing on emotional health, creating evidence-based and precise nutritional solutions.Scientific Commitment: Building a strong foundation of safety and efficacy with pharmaceutical-grade standards.Brand Vision: To become a leading brand in emotional health expertise and empower global emotional well-being.